Cargando…
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147040/ https://www.ncbi.nlm.nih.gov/pubmed/34034644 http://dx.doi.org/10.1186/s10194-021-01253-3 |
| _version_ | 1783697537750794240 |
|---|---|
| author | Smith, Timothy R. Spierings, Egilius L. H. Cady, Roger Hirman, Joe Schaeffler, Barbara Shen, Vivienne Sperling, Bjørn Brevig, Thomas Josiassen, Mette Krog Brunner, Elizabeth Honeywell, Loan Mehta, Lahar |
| author_facet | Smith, Timothy R. Spierings, Egilius L. H. Cady, Roger Hirman, Joe Schaeffler, Barbara Shen, Vivienne Sperling, Bjørn Brevig, Thomas Josiassen, Mette Krog Brunner, Elizabeth Honeywell, Loan Mehta, Lahar |
| author_sort | Smith, Timothy R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8147040 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Milan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81470402021-05-25 Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials Smith, Timothy R. Spierings, Egilius L. H. Cady, Roger Hirman, Joe Schaeffler, Barbara Shen, Vivienne Sperling, Bjørn Brevig, Thomas Josiassen, Mette Krog Brunner, Elizabeth Honeywell, Loan Mehta, Lahar J Headache Pain Correction Springer Milan 2021-05-25 /pmc/articles/PMC8147040/ /pubmed/34034644 http://dx.doi.org/10.1186/s10194-021-01253-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Smith, Timothy R. Spierings, Egilius L. H. Cady, Roger Hirman, Joe Schaeffler, Barbara Shen, Vivienne Sperling, Bjørn Brevig, Thomas Josiassen, Mette Krog Brunner, Elizabeth Honeywell, Loan Mehta, Lahar Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials |
| title | Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials |
| title_full | Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials |
| title_fullStr | Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials |
| title_full_unstemmed | Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials |
| title_short | Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials |
| title_sort | correction to: safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147040/ https://www.ncbi.nlm.nih.gov/pubmed/34034644 http://dx.doi.org/10.1186/s10194-021-01253-3 |
| work_keys_str_mv | AT smithtimothyr correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT spieringsegiliuslh correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT cadyroger correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT hirmanjoe correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT schaefflerbarbara correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT shenvivienne correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT sperlingbjørn correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT brevigthomas correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT josiassenmettekrog correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT brunnerelizabeth correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT honeywellloan correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials AT mehtalahar correctiontosafetyandtolerabilityofeptinezumabinpatientswithmigraineapooledanalysisof5clinicaltrials |